Earnest

The Market Hates Mosaic: Phosphates Not Up to Snuff

I shared your frustration. It's hard to stomach that fundmental doesn't count anymore. It's more like an cat-mice game by the analysts. I wonder why Merrill downgraded the sector but did not lower the "price target"? Even S&P has $165 for CF, which was down a good 35% with MOS.

In looking at MOS's earning estimates in the past few quarters, only 4 analysts gave estimate and with a difference of 0.20. How's that an earning estimate statistical signaficance? Ironically, one of the 4 actually raised estimate last month! So, are our analysts only look at rear mirror?